Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. (Q33298434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

hepatocellular carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

John M. Luk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Stella Sun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Nikki P Y Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ronnie T P Poon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sheung-Tat Fan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

George K Lau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1021-1038

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17845530%20AND%20SRC:MED&resulttype=core&format=json

Estimating the world cancer burden: Globocan 2000.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomics for hepatocellular carcinoma marker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteome chips for whole-organism assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Protein microarrays as tools for functional proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Analysis of protein interactions on protein arrays by a wavelength interrogation-based surface plasmon resonance biosensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Profiling protein function with small molecule microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Antibody-based proteomics for human tissue profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Convergence of the proteomic pattern in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Direct analysis of protein complexes using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Human tissue profiling with multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry (LC-FTICR MS): an early overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

The Orbitrap: a new mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

21 January 2018

Laser capture microscopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

The development of the DIGE system: 2D fluorescence difference gel analysis technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomics for the early detection and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Gene expression of apolipoprotein E in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Apolipoprotein E phenotype, cholesterol and breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

The ubiquitin-proteasome proteolytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

The oncoprotein 18/stathmin family of microtubule destabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

[The stathmin-tubulin interaction and the regulation of the microtubule assembly]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Challenging accepted ion channel biology: p64 and the CLIC family of putative intracellular anion channel proteins (Review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Serum markers of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Complement resistance of tumor cells: basal and induced mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Inhibition of Daxx-mediated apoptosis by heat shock protein 27

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Distribution of Hsp-27 and HER-2/neu in in situ and invasive ductal breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Changes in serum alpha1 antitrypsin, alpha1 acid glycoprotein and beta2 glycoprotein i in patients with malignant hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Mechanisms of Human Hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Characterizing phosphoproteins and phosphoproteomes using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Wnt/Frizzled signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Regulation of Wnt signaling by protein-protein interaction and post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Regulatory mechanisms and function of ERK MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Mitogen-activated protein kinases, adherens junction dynamics, and spermatogenesis: a review of recent data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Hepatitis viruses and the MAPK pathway: is this a survival strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Anti-TGF-beta strategies for the treatment of chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Dynamics of MAL2 during glycosylphosphatidylinositol-anchored protein transcytotic transport to the apical surface of hepatoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

21 January 2018

Alcohol and liver cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01533.X